The purpose of this study is to compare overall survival for patients receiving ipilimumab plus bevacizumab versus ipilimumab alone.
Cancer,
Cancer - Brain,
Cancer - Breast,
Cancer - Colon,
Cancer - Esophogus,
Cancer-Gynecologic,
Cancer - Kidney,
Cancer - Leukemia,
Cancer - Lung,
Cancer - Lymphoma,
Cancer - Melanoma,
Cancer - Multiple Myeloma,
Cancer - Pancreatic,
Cancer - Prostate
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
Cancer,
Cancer - Brain,
Cancer - Breast,
Cancer - Colon,
Cancer - Esophogus,
Cancer-Gynecologic,
Cancer - Kidney,
Cancer - Leukemia,
Cancer - Lung,
Cancer - Lymphoma,
Cancer - Melanoma,
Cancer - Multiple Myeloma,
Cancer - Pancreatic,
Cancer - Prostate
- D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
-
Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
The purpose of this study is to compare the effects, good and/or bad, of the experimental drug MK-3475 (also called pembrolizumab) to the usual treatment of either interferon alfa-2b or ipilimumab. In this study, you will get either MK-3475 or a choice of either interferon alfa-2b or ipilimumab.
Cancer - Melanoma
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
Cancer,
Cancer - Melanoma
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
Page 1 of 1 | Results 1 - 6 of 6